Skip to main content

Advertisement

Fig. 6 | Cell & Bioscience

Fig. 6

From: Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination

Fig. 6

Comparison of OVA-specific CD8+ T cell responses induced by pcDNA3-OVA vaccination with or without co-administration of BPV L1 or L2. a. Schematic illustration of the experiment. Briefly, 5 ~ 8 weeks old female C57BL/6 mice (3 mice/group) were vaccinated with 10 μg/mouse of pcDNA3-OVA, with either 10 μg/mouse of pcDNA3, or pcDNA3-BPVL1, or pcDNA3-BPVL2 via intramuscular injection. The mice were boosted with the same regimen once after one week. 7 days after the last vaccination, PBMCs were collected from peripheral blood, stained with FITC-conjugated anti-mouse CD8a antibody, PE-conjugated OVA peptide (SIINFEKL) loaded H-2Kb tetramer. The data were acquired with FACSCalibur and analyzed with CellQuest. b. Representative flow cytometry image of PBMC staining. c. Summary of the flow cytometry data

Back to article page